Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
3,090
-1,625
-34% -$556K 0.47% 32
2026
Q1
$1.66M Sell
4,715
-183
-4% -$65.2K 0.82% 22
2025
Q4
$1.6M Buy
4,898
+220
+5% +$69.8K 0.83% 20
2025
Q3
$1.32M Sell
4,678
-79
-2% -$22.9K 0.74% 21
2025
Q2
$1.33M Buy
4,757
+396
+9% +$112K 0.84% 18
2025
Q1
$1.36M Sell
4,361
-10
-0.2% -$2.95K 0.96% 19
2024
Q4
$1.14M Buy
4,371
+102
+2% +$30.3K 0.75% 17
2024
Q3
$1.38M Buy
4,269
+132
+3% +$43.2K 0.92% 15
2024
Q2
$1.29M Buy
4,137
+145
+4% +$42.6K 0.95% 15
2024
Q1
$1.07M Buy
3,992
+1,387
+53% +$406K 0.83% 16
2023
Q4
$750K Buy
+2,605
New +$710K 0.61% 24

Other funds holding AMGN

Visionary Horizons's AMGN Position: Q2 2026 in Review

Visionary Horizons reduced its Amgen (AMGN) stake by 34% in Q2 2026, selling an estimated $556K and leaving 3,090 shares worth $1.12M. The position accounts for 0.47% of the portfolio, ranked #32.

Visionary Horizons first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.66M in Q1 2026. 1,540 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Visionary Horizons held 3,090 shares of Amgen worth $1.12M as of Q2 2026.
  • Visionary Horizons sold 1,625 Amgen shares in Q2 2026, an estimated $556K.
  • Amgen made up 0.47% of Visionary Horizons's portfolio in Q2 2026, its #32 holding.
  • Visionary Horizons first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Visionary Horizons's Amgen position peaked at $1.66M in Q1 2026.
  • 1,540 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Visionary Horizons's 13F filing for Q2 2026, filed 16 Jul 2026.